Long-term depot-medroxyprogesterone acetate and bone mineral density

Area of Science:

• Endocrinology
• Bone Metabolism
• Reproductive Health

Background:

• The relationship between depot-medroxyprogesterone acetate (DMPA) and bone mineral density (BMD) remains debated.
• Previous case-control studies in diverse populations yielded conflicting results.

Purpose of the Study:

• To investigate the association between long-term DMPA use and BMD in Chinese women.
• To compare BMD in DMPA users with a control group of non-steroidal hormone users.

Main Methods:

• A case-controlled study involving 67 Chinese women with 5-15 years of DMPA use.
• Comparison with 218 age-matched women who had not used steroidal hormones.
• BMD measurements at lumbar vertebra, neck of femur, trochanter, and Ward's triangle.

Main Results:

• DMPA users exhibited significantly lower BMD across all measured sites compared to controls (p < 0.001).
• Estimated annual bone loss ranged from 1.1% to 3.5% in DMPA users.
• Bone loss at the lumbar spine was more pronounced with increasing age.

Conclusions:

• Long-term DMPA use (>5 years) is associated with significant bone loss in Chinese women.
• Findings suggest DMPA may negatively impact bone health in this population.
• Further prospective studies are recommended to confirm these results.